Similar articles

• Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.

  Campbell AC, Skinner JM, Maclennan IC, Hersey P, Waller CA, Wood J, Jewell DP, Truelove SC. Campbell AC, et al. Clin Exp Immunol. 1976 May;24(2):249-58. Clin Exp Immunol. 1976. PMID: 776464 Free PMC article. Clinical Trial.
• Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine.

  Campbell AC, Skinner JM, Hersey P, Roberts-Thomson P, MacLennan IC, Truelove SC. Campbell AC, et al. Clin Exp Immunol. 1974 Apr;16(4):521-33. Clin Exp Immunol. 1974. PMID: 4468852 Free PMC article.
• The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.

  Glas J, Török HP, Daczo J, Tonenchi L, Folwaczny M, Folwaczny C. Glas J, et al. Eur J Med Res. 2005 Dec 7;10(12):535-8. Eur J Med Res. 2005. PMID: 16356870 Clinical Trial.
• The immunology of inflammatory bowel disease.

  MacKechnie HL. MacKechnie HL. Henry Ford Hosp Med J. 1982;30(1):25-32. Henry Ford Hosp Med J. 1982. PMID: 6123493 Review. No abstract available.
• Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?

  Sands BE. Sands BE. Gut. 2006 Apr;55(4):437-41. doi: 10.1136/gut.2005.078055. Gut. 2006. PMID: 16531519 Free PMC article. Review.